Global Cataract Surgery Devices Market By Type (Equipment, Consumables), Product (Intraocular Lens, Ophthalmic Viscoelastic Device, Phacoemulsification Equipment), End User (Hospitals, Ophthalmology Clinics, Ambulatory Surgery Centers)
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Global Cataract Surgery Devices Market size is expected to reach $10.0 billion by 2024, rising at a market growth of 4.8% CAGR during the forecast period. Cataract surgery devices are majorly used in surgical procedures that are focused on treating cataract, an eye disorder which clouds the lens, and as a result, leads to defects in vision. Cataract is among the most common diseases which leads to blindness, reducing vision ability. Cataract is known to develop slowly and affects either one or both the eyes. Cataract does not directly interfere with the eyesight in its early stages; nevertheless, it interferes with vision and leads blindness over the years. Increase in incidences of diseases such as diabetes, obesity, hypertension and growth in geriatric population contributes to the growth of the market.
Cataract surgery devices are majorly used in surgical procedures that are focused on treating cataract, an eye disorder which clouds the lens, and as a result, leads to defects in vision. Cataract is among the most common diseases which lead to blindness, reducing vision ability. Cataract is known to develop slowly and affects either one or both the eyes.
Cataract does not directly interfere with the eyesight in its early stages; nevertheless, it interferes with vision and leads blindness over the years. The symptoms of cataract are blurry vision, trouble with bright lights, faded colors, and night blindness. Cataract surgery is among the most common ophthalmic procedures; therefore, potential for the growth of cataract surgery devices is unprecedented.
Cataract Surgery is a process used to remove the eye’s clouded natural lens and replace the same with an artificial lens to restore vision. If cataract is not removed surgically, it is possible to suffer from blurred vision, if not complete blindness. Surgery is the only way to fully restore vision. The cataract operation is generally an outpatient procedure, where the patients are discharged immediately after the surgery. Cataracts are the common cause for impaired vision and are particularly impacting people in the developing countries, where they commonly lead to blindness. The risk of cataract increases with each decade of life starting at the age of 40. By the age of 75, it is estimated that half of Americans have cataract. By age 80, 70 percent of American population has cataract.
Cataract Surgery Devices Market Size
Based on Type, the market is segmented into Consumables and Equipment. Based on Product, the market is segmented into Ophthalmic Viscoelastic Device (OVD), Intraocular Lens (IOL) and Phacoemulsification Equipment. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers (ASCs) and Ophthalmology Clinics. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
Cataract Surgery Devices Market Share
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Novartis Ag, Abbott Laboratories, Carl Zeiss Meditec Ag, Essilor International S.A, Johnson & Johnson, Metall Zug AG, Topcon Corporation, Nidek Co., Ltd, Valeant Pharmaceuticals International, Inc. and Ziemer Ophthalmic Systems Ag.
Scope of the Study
- Ophthalmic Viscoelastic Device (OVD)
- Intraocular Lens (IOL)
- Phacoemulsification Equipment.
By End User
- Ambulatory Surgery Centers (ASCs) and
- Ophthalmology Clinics
- Rest of Europe
- North America
- Rest of North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Novartis Ag
- Abbott Laboratories
- Carl Zeiss Meditec Ag
- Essilor International S.A
- Johnson & Johnson
- Metall Zug AG
- Topcon Corporation
- Nidek Co., Ltd
- Valeant Pharmaceuticals International, Inc.
- Ziemer Ophthalmic Systems Ag
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free